Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Laryngeal Neoplasms × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

Cetuximab 6 Cisplatin 5 Radiotherapy, Intensity-Modulated 4 pembrolizumab 2 durvalumab 2 Fluorouracil 2 Docetaxel 2 Celecoxib 2 Carboplatin 2 Bupropion 2 130-nm albumin-bound paclitaxel 2 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Radiotherapy 1 Radiation 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 Immunoglobulin G 1 Hydroxyurea 1 Gene Expression Profiling 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Erlotinib Hydrochloride 1 Early Intervention, Educational 1 Drug Therapy 1 Disulfides 1 Dihematoporphyrin Ether 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡